Artemether & Lumefantrine Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP manufactures Artemether & Lumefantrine Tablets for treatment of acute uncomplicated malaria caused by Plasmodium falciparum. The formulation is widely used in antimalarial therapy programs for rapid parasite clearance and malaria fever control.

Artemether delivers fast antimalarial activity by reducing parasite load quickly, while Lumefantrine provides prolonged action to eliminate remaining malaria parasites and reduce recurrence risk. Recognized as an Antimalarial Tablets Supplier, Genliva Wellness LLP develops combination antimalarial formulations with dependable therapeutic effectiveness and stable tablet quality.

Operating as an Artemether Lumefantrine Tablets Manufacturer in India and Malaria Treatment Medicine Exporter, Genliva Wellness LLP supplies antimalarial medicines for pharmaceutical distributors and international healthcare organizations.

Artemether & Lumefantrine Tablets are formulated for combination antimalarial therapy and malaria infection control.

Artemisinin-based combination tablet formulation
Rapid action against malaria parasites
Effective in uncomplicated falciparum malaria treatment
Manufactured using quality pharmaceutical ingredients
Stable oral tablet dosage form

This formulation is commonly used for malaria infection treatment and antimalarial therapies.

Treatment of uncomplicated falciparum malaria
Management of malaria fever and chills
Used in antimalarial treatment programs
Reduces malaria parasite load effectively
Improves recovery from malaria infections
Used in oral malaria therapy protocols

Artemether & Lumefantrine Tablets provide dual antimalarial action for effective malaria treatment.

Rapidly reduces malaria parasite count
Helps prevent recurrence of malaria infection
Useful in falciparum malaria treatment
Delivers fast fever control during malaria episodes
Provides combination antimalarial effectiveness